Impact of Atrial Fibrillation Prediction Model on Prescribing Oral Anti-Coagulation in Patients With Cryptogenic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

Also called NCT07934511

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Samir Saba (from the registry)
Registry
  • NCT NCT07934511
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07934511. Allocation not applicable; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2028-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Atrial Fibrillation Prediction Model on Prescribing Oral Anti-Coagulation in Patients With Cryptogenic Stroke
Condition
Stroke
Intervention (Device)
UPMC AF Prediction Model
Lead sponsor
Samir Saba (class: other)

Record details

Record id
cardio:ct-nct07934511
Content hash
3ba6a75dee12644c373cf6f858d573d760a6d98ce6f9f04f0b155b2025196a74